Peer reviewed publications

R. Sinkus, B.E. Van Beers, V. Vilgrain, N. DeSouza, J.C. WatertonApparent diffusion coefficient from magnetic resonance imaging as a biomarker in oncology drug developmentEuropean Journal of Cancer2012484425-431
D. Soloviev, D. Lewis, D. Honess, E. Aboagye[18F]FLT: An imaging biomarker of tumour proliferation for assessment of tumour response to treatment.European Journal of Cancer2012484416-424
Q. Nguyen, A. Challapalli , G. Smith , R. Fortt, E.O. AboagyeImaging apoptosis with positron emission tomography: ‘Bench to bedside’ development of the caspase-3/7 specific radiotracer [18F]ICMT-11.European Journal of Cancer2012484432-440
J.C. Waterton, L. PylkkaanenQualification of imaging biomarkers for oncology drug development.European Journal of Cancer2012484409-415
P. Lambin, E. Rios-Velazquez, R. Leijenaar, S. Carvalho, R. GPM van Stiphout, P. Granton, C. ML Zegers, R. Gillies, R. Boellard, A. Dekker, H. JWL AertsRadiomics: Extracting more information from medical images using advanced feature analysis.European Journal of Cancer2012484441-446
M.-C. Asselin, J. PB O’Connor, R. Boellaard, N. A Thacker, A. JacksonQuantifying heterogeneity in human tumours using MRI and PET.European Journal of Cancer2012484447-455
V. Frings, A.J. de Langen, M. Yaqub, R.C. Schuit,
A.A.M. van der Veldt, O.S. Hoekstra, E.F. Smit, R. Boellaard
Methodological Considerations in Quantification
of 3'-Deoxy-3'-[18F]Fluorothymidine Uptake
Measured with Positron Emission Tomography
in Patients with Non-Small Cell Lung Cancer
Molecular Imaging and Biology2013
R.T.H. Leijenaar, S. Carvalho, E. Rios Velazquez, W.J.C. van Elmpt, C. Parmar, O.S. Hoekstra, C.J. Hoekstra, R. Boellaard, A.L.A.J. Dekker, R.J. Gillies, H.J.W.L. Aerts, P. LambinStability of FDG-PET Radiomics features: an integrated analysis of test-retest and inter-observer variability
Acta Oncologica2013521391-1397
S. Carvalho, R.T.H. Leijenaar, E. Rios Velazquez, C. Oberije, C. Parmar, W. van Elmpt, B. Reymen, E..G.C. Troost, M. Oellers, A. Dekker, R. Gillies, H.J.W.L. Aerts, P. LambinPrognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer.
Acta Oncologica2013521398-1404
P. Lambin, E. Roelofs, B. Reymen, E. Rios Velazquez, J. Buijsen, K. Zegers, S. Carvalho, R. Leijenaar, G. Nalbantov, C. Oberije, M. Scott Marshall, F. Hoebers, E.G.C. Troost, R.G.P.M. van Stiphout, W. van Elmpt, T. van der Weijden, L. Boersma, V. Valentini, A. Dekker‘Rapid Learning health care in oncology’ – An approach towards decision support systems enabling customised radiotherapy’.Radiotherapy and Oncology2013
V. Frings, A.A. van der Veldt, R. Boellaard, G.J. Herder, E. Giovannetti, R. Honeywell, G.J. Peters, E. Thunnissen, O.S. Hoekstra, E.F. SmitPemetrexed induced thymidylate synthase inhibition in non-small cell lung cancer patients: a pilot study with 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography.PLoS One201385e63705
L. Bernardin, N. Hogg, D. Collins, S. Giles, E. O’Flynn, M. Orton, N.M. deSouzaDiffusion weighted magnetic resonance imaging for assessment of lung lesions: repeatability of the apparent diffusion coefficient measurementEuropean Radiology (in press)
H. Ragheb, N.A. Thacker, D.M. Morris, N.H.M. Hogg, A. JacksonIce-Water Phantom Localisation for Diffusion Calibration.Medical Image Understanding and Analysis (MIUA), Swansea University, Swansea, UK2012179-184
J.C. Waterton, D. LacombeQuIC-ConCePT: Quantitative imaging in oncology-connecting cellular processes to therapy.European Journal of Cancer20124874
Starmans M.H., Pintilie M., John T., Der S.D., Shepherd F.A., Jurisica I., Lambin P., Tsao M.S., Boutros P.C.Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies.Genome Medicine201241184
Rios Velazquez E., Aerts H.J., Gu Y., Goldgof D.B., De Ruysscher D., Dekker A., Korn R., Gillies R.J., Lambin P.A semiautomatic CT-based ensemble segmentation of lung tumors: Comparison with oncologists' delineations and with the surgical specimen.Radiotherapy & Oncology20121052167-173
van der Heide U.A., Houweling A.C., Groenendaal G., Beets-Tan R.G., Lambin P.Functional MRI for radiotherapy dose painting.Magnetic Resonance Imaging20123091216-1223
Lambin P., van Stiphout R.G., Starmans M.H., Rios-Velazquez E., Nalbantov G., Aerts H.J., Roelofs E., van Elmpt W., Boutros P.C., Granone P., Valentini V., Begg A.C., De Ruysscher D., Dekker A.Predicting outcomes in radiation oncology-multifactorial decision support systems.Nature Reviews Clinical Oncology201310127-40
Carvalho S., Leijenaar R.T., Velazquez E.R., Oberije C., Parmar C., van Elmpt W., Reymen B., Troost E.G., Oellers M., Dekker A., Gillies R., Aerts H.J., Lambin P.Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer.Acta Oncologica20135271398-1404
E. Roelofs, L. Persoon, S. Nijsten, W. Wiessler, A. Dekker, P. LambinBenefits of a clinical data warehouse with data mining tools to collect data for a radiotherapy trial.Radiotherapy & Oncology20131081174-179
Leijenaar R.T., Carvalho S., Velazquez E.R., van Elmpt W.J., Parmar C., Hoekstra O.S., Hoekstra C.J., Boellaard R., Dekker A.L., Gillies R.J., Aerts H.J., Lambin P.Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variabilityActa Oncologica20135271391-1397
Timothy H. Witney, Robin R. Fortt, Eric O. AboagyePreclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by 18F-ICMT-11-Positron Emission TomographyPLoS One201493e91694
Hugo J. W. L. Aerts, Emmanuel Rios Velazquez, Ralph T. H. Leijenaar, Chintan Parmar, Patrick Grossmann, Sara Cavalho, Johan Bussink, René Monshouwer, Benjamin Haibe-Kains, Derek Rietveld, Frank Hoebers, Michelle M. Rietbergen, C. René Leemans, Andre Dekker, John Quackenbush, Robert J. Gillies, and Philippe LambinDecoding tumour phenotype by noninvasive imaging using a quantitative radiomics approachNature Communications201454006
Virginie Frings, Maqsood Yaqub, Lieke L. Hoyng, Sandeep S.V. Golla, Albert D. Windhorst, Robert C. Schuit, Adriaan A. Lammertsma,
Otto S. Hoekstra, Egbert F. Smit, Ronald Boellaard
Assessment of Simplified Methods to Measure 18F-FLT Uptake Changes in EGFR-Mutated Non–Small Cell Lung Cancer Patients Undergoing EGFR Tyrosine Kinase Inhibitor TreatmentThe Journal of Nuclear Medicine20145591417-1423
Sonja Schelhaas,
Lydia Wachsmuth, Thomas Viel, Davina J. Honess, Kathrin Heinzmann, Donna-Michelle Smith, Sven Hermann, Stefan Wagner, Michael T. Kuhlmann, Carsten Müller-Tidow, Klaus Kopka,
Otmar Schober, Michael Schäfers,
Richard Schneider, Eric O. Aboagye,
John Griffiths, Cornelius Faber, Andreas H. Jacobs
Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3′-Deoxy-3′-18F-Fluorothymidine PET and Diffusion-Weighted MR ImagingThe Journal of Nuclear Medicine2014556983-988
Emmanuel Rios Velazquez, Chintan Parmar, Mohammed Jermoumi1,3, Raymond H. Mak,
Angela van Baardwijk, Fiona M. Fennessy, John H. Lewis, Dirk De Ruysscher, Ron Kikinis,
Philippe Lambin, Hugo J. W. L. Aerts
Volumetric CT-based segmentation of
NSCLC using 3D-Slicer
Scientific Reports201333529
Bernardin L, Douglas NH, Collins DJ, Giles SL, O'Flynn EA, Orton M, deSouza NM.Diffusion-weighted magnetic resonance imaging for assessment of lung lesions: repeatability of the apparent diffusion coefficient measurementEuropean Radiology2014242502-511
Livia Bernardin, Elizabeth A.M. O’Flynn, Nandita M. deSouzaFunctional imaging biomarkers for assessing response to treatment in liver and lung metastasesCancer Imaging2013134482-494
Virginie Frings, Adrianus J. de Langen, Maqsood Yaqub, Robert C. Schuit, Astrid A. M. van der Veldt, Otto S. Hoekstra, Egbert F. Smit, Ronald BoellaardMethodological Considerations in Quantificationof 3'-Deoxy-3'-[18F]Fluorothymidine Uptake Measured with Positron Emission Tomography in Patients with Non-Small Cell Lung CancerMolecular Imaging and Biology2014161136-145
Natalie S Fox, Maud HW Starmans, Syed Haider, Philippe Lambin, Paul C BoutrosEnsemble analyses improve signatures of tumour
hypoxia and reveal inter-platform differences
BMC Bioinformatics201415170

IMI oncology projects